Register for our free email digests:
Latest From Hexal AG
A united Sun Pharma and Ranbaxy may become a strong global generics firm but its fallout on the Indian market is being studied carefully. Consumer activists have upped their ante raising concerns of impending market dominance in several areas.
Generics manufacturers are pressing for the removal of tamper-evident packaging requirements in the EU’s Falsified Medicines Directive, saying it will cost them almost $700 million.
Counterfeit omeprazole has been found for the third time in Germany, suggesting that the generics sector must raise its game to combat this phenomenon.
The new German drug register is designed to be a first step in tackling potential drug shortages on the domestic market, but it currently lacks effective solutions.
- Surgical Equipment & Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Rhytec Inc.
- Senior Management
Mark Goble, MD, CEO
Ken Grant, VP, Mktg. & Bus. Dev.
- Contact Info
Phone: (781) 290-0545
1000 Winter St.
Waltham, MA 02451
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.